Description
A prodrug form of tedizolid; reduces vegetation titer in a rabbit model of aortic valve endocarditis caused by MRSA (15 mg/kg); reduces densities of methicillin-susceptible S. aureus and MRSA infection in a mouse model of catheter-related biofilm infection; increases survival in a rabbit model of MRSA necrotizing pneumonia
Formal name: (5R)-3-[3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone
Synonyms: TR-701 FA
Molecular weight: 450.3
CAS: 856867-55-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics|Oxazolidinones||Research Area|Cardiovascular System|Heart||Research Area|Cardiovascular System|Vasculature||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|MRSA||Research Area|Infectious Disease|Bacterial Diseases|Pneumonia